Effect of early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting on cancer-specific survival in metastatic castrate-resistant prostate cancer - Lehner, K; Ahmed, ME; Bole, R (American Society of Clinical Oncology, 2023)